
Mark L. Berch
Examiner (ID: 99)
| Most Active Art Unit | 1202 |
| Art Unit(s) | 1202, 1624, 1622, 1802, 2899, 1614, 1611 |
| Total Applications | 3573 |
| Issued Applications | 2301 |
| Pending Applications | 170 |
| Abandoned Applications | 1103 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6537590
[patent_doc_number] => 20020193378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Optically active 5H-pyrrolo[3,4-b]pyrazine derivative, its preparation and pharmaceutical compositions containing it'
[patent_app_type] => new
[patent_app_number] => 10/200510
[patent_app_country] => US
[patent_app_date] => 2002-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1568
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20020193378.pdf
[firstpage_image] =>[orig_patent_app_number] => 10200510
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/200510 | Optically active 5H-pyrrolo[3,4-b]pyrazine derivative, its preparation and pharmaceutical compositions containing it | Jul 22, 2002 | Issued |
Array
(
[id] => 1009550
[patent_doc_number] => 06900312
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-31
[patent_title] => 'Thiazole-substituted β-lactams'
[patent_app_type] => utility
[patent_app_number] => 10/196052
[patent_app_country] => US
[patent_app_date] => 2002-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1307
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/900/06900312.pdf
[firstpage_image] =>[orig_patent_app_number] => 10196052
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/196052 | Thiazole-substituted β-lactams | Jul 15, 2002 | Issued |
Array
(
[id] => 6843712
[patent_doc_number] => 20030149059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Tetrahydropurinones and derivatives thereof as corticotropin releasing factor receptor ligands'
[patent_app_type] => new
[patent_app_number] => 10/192061
[patent_app_country] => US
[patent_app_date] => 2002-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25863
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20030149059.pdf
[firstpage_image] =>[orig_patent_app_number] => 10192061
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/192061 | Tetrahydropurinones and derivatives thereof as corticotropin releasing factor receptor ligands | Jul 9, 2002 | Issued |
Array
(
[id] => 6330996
[patent_doc_number] => 20020198379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-26
[patent_title] => 'Active compound from a sponge'
[patent_app_type] => new
[patent_app_number] => 10/184724
[patent_app_country] => US
[patent_app_date] => 2002-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1689
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20020198379.pdf
[firstpage_image] =>[orig_patent_app_number] => 10184724
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/184724 | Active compound from a sponge | Jun 27, 2002 | Abandoned |
Array
(
[id] => 6797562
[patent_doc_number] => 20030176436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Novel heterocyclic compounds as selective bacterial DHFR inhibitors and their uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/184855
[patent_app_country] => US
[patent_app_date] => 2002-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12906
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20030176436.pdf
[firstpage_image] =>[orig_patent_app_number] => 10184855
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/184855 | Novel heterocyclic compounds as selective bacterial DHFR inhibitors and their uses thereof | Jun 27, 2002 | Abandoned |
Array
(
[id] => 6830412
[patent_doc_number] => 20030181470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/185059
[patent_app_country] => US
[patent_app_date] => 2002-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17680
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20030181470.pdf
[firstpage_image] =>[orig_patent_app_number] => 10185059
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/185059 | Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitors | Jun 27, 2002 | Issued |
Array
(
[id] => 1150506
[patent_doc_number] => 06770651
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-08-03
[patent_title] => 'A2B adenosine receptor antagonists'
[patent_app_type] => B2
[patent_app_number] => 10/184494
[patent_app_country] => US
[patent_app_date] => 2002-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17006
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 280
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/770/06770651.pdf
[firstpage_image] =>[orig_patent_app_number] => 10184494
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/184494 | A2B adenosine receptor antagonists | Jun 26, 2002 | Issued |
Array
(
[id] => 1281847
[patent_doc_number] => 06642231
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-11-04
[patent_title] => '6,9-disubstituted 2-trans-(4-aminocyclohexyl)amino purines'
[patent_app_type] => B2
[patent_app_number] => 10/178494
[patent_app_country] => US
[patent_app_date] => 2002-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67435
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 774
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/642/06642231.pdf
[firstpage_image] =>[orig_patent_app_number] => 10178494
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/178494 | 6,9-disubstituted 2-trans-(4-aminocyclohexyl)amino purines | Jun 23, 2002 | Issued |
Array
(
[id] => 6688910
[patent_doc_number] => 20030032635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Heterocyclic esters and amides'
[patent_app_type] => new
[patent_app_number] => 10/177666
[patent_app_country] => US
[patent_app_date] => 2002-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6413
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20030032635.pdf
[firstpage_image] =>[orig_patent_app_number] => 10177666
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/177666 | Heterocyclic esters and amides | Jun 23, 2002 | Abandoned |
Array
(
[id] => 6651924
[patent_doc_number] => 20030105115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Novel pyridopyrimidines and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/176790
[patent_app_country] => US
[patent_app_date] => 2002-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37292
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20030105115.pdf
[firstpage_image] =>[orig_patent_app_number] => 10176790
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/176790 | Novel pyridopyrimidines and uses thereof | Jun 20, 2002 | Abandoned |
Array
(
[id] => 6766172
[patent_doc_number] => 20030100572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-29
[patent_title] => 'Novel pyridopyrimidones and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/177520
[patent_app_country] => US
[patent_app_date] => 2002-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39951
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20030100572.pdf
[firstpage_image] =>[orig_patent_app_number] => 10177520
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/177520 | Novel pyridopyrimidones and uses thereof | Jun 20, 2002 | Abandoned |
Array
(
[id] => 6669483
[patent_doc_number] => 20030114467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Novel pyrazolo- and pyrrolo-pyrimidines and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/177563
[patent_app_country] => US
[patent_app_date] => 2002-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41062
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20030114467.pdf
[firstpage_image] =>[orig_patent_app_number] => 10177563
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/177563 | Novel pyrazolo- and pyrrolo-pyrimidines and uses thereof | Jun 20, 2002 | Abandoned |
Array
(
[id] => 1073894
[patent_doc_number] => 06838559
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-01-04
[patent_title] => 'Purine inhibitors of phosphodiesterase (PDE) 7'
[patent_app_type] => utility
[patent_app_number] => 10/173530
[patent_app_country] => US
[patent_app_date] => 2002-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15326
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/838/06838559.pdf
[firstpage_image] =>[orig_patent_app_number] => 10173530
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/173530 | Purine inhibitors of phosphodiesterase (PDE) 7 | Jun 16, 2002 | Issued |
Array
(
[id] => 774281
[patent_doc_number] => 07002012
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-02-21
[patent_title] => 'Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-YI)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders'
[patent_app_type] => utility
[patent_app_number] => 10/174414
[patent_app_country] => US
[patent_app_date] => 2002-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17642
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/002/07002012.pdf
[firstpage_image] =>[orig_patent_app_number] => 10174414
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/174414 | Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-YI)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders | Jun 16, 2002 | Issued |
Array
(
[id] => 6693090
[patent_doc_number] => 20030040522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-27
[patent_title] => 'Process for the production of N-[3-(3-cyanopyrazolo[1,5-a] pyrimidin-7-yl) phenyl]-N-ethylacetamide (zaleplon)'
[patent_app_type] => new
[patent_app_number] => 10/170673
[patent_app_country] => US
[patent_app_date] => 2002-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4220
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20030040522.pdf
[firstpage_image] =>[orig_patent_app_number] => 10170673
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/170673 | Process for the production of N-[3-(3-cyanopyrazolo[1,5-a] pyrimidin-7-yl) phenyl]-N-ethylacetamide (zaleplon) | Jun 11, 2002 | Issued |
Array
(
[id] => 6693074
[patent_doc_number] => 20030040506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-27
[patent_title] => 'Analogs of (1s,cis)-4-(2-amino-9h-purin -9-yl) -2-Cyclopentene-1-methanol as antiviral'
[patent_app_type] => new
[patent_app_number] => 10/149198
[patent_app_country] => US
[patent_app_date] => 2002-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11158
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20030040506.pdf
[firstpage_image] =>[orig_patent_app_number] => 10149198
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/149198 | Analogs of (1s,cis)-4-(2-amino-9h-purin -9-yl) -2-Cyclopentene-1-methanol as antiviral | Jun 9, 2002 | Abandoned |
Array
(
[id] => 6750987
[patent_doc_number] => 20030045508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => '(1r,cis)-4-(4-amino-7h-pyrrolo\'2,3-i(d) pyrimidine-7-yl)-2-cyclopentene-1-methanol derivatives as antiviral'
[patent_app_type] => new
[patent_app_number] => 10/149457
[patent_app_country] => US
[patent_app_date] => 2002-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8774
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20030045508.pdf
[firstpage_image] =>[orig_patent_app_number] => 10149457
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/149457 | (1r,cis)-4-(4-amino-7h-pyrrolo'2,3-i(d) pyrimidine-7-yl)-2-cyclopentene-1-methanol derivatives as antiviral | Jun 9, 2002 | Abandoned |
Array
(
[id] => 560965
[patent_doc_number] => 07157576
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-02
[patent_title] => 'Crystalline acid salts of cefdinir and process for preparing cefdinir using same'
[patent_app_type] => utility
[patent_app_number] => 10/479291
[patent_app_country] => US
[patent_app_date] => 2002-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2726
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/157/07157576.pdf
[firstpage_image] =>[orig_patent_app_number] => 10479291
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/479291 | Crystalline acid salts of cefdinir and process for preparing cefdinir using same | Jun 4, 2002 | Issued |
Array
(
[id] => 1151491
[patent_doc_number] => 06770759
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-08-03
[patent_title] => 'Penicillanic acid derivative compounds and methods of making'
[patent_app_type] => B2
[patent_app_number] => 10/163684
[patent_app_country] => US
[patent_app_date] => 2002-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16870
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 592
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/770/06770759.pdf
[firstpage_image] =>[orig_patent_app_number] => 10163684
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/163684 | Penicillanic acid derivative compounds and methods of making | Jun 4, 2002 | Issued |
| 10/069030 | Novel crystalline form of disodium n-{4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]-benzoyl]l-glutamic acid salt and processes therefor | Jun 3, 2002 | Abandoned |